World Hematology and Flow Cytometry Analyzer and Reagent Markets, 2021-2025-Supplier Shares, Segment Forecasts, Growth Opportunities in 97 Countries—Competitive Strategies, Instrumentation Pipeline, Latest Technologies
This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source.
The report is available by section, and can be customized to specific information needs and budget.
This survey from LeadingMarketResearch.com provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities emerging in the global hematology and flow cytometry markets during the next five years.
Rationale
Continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays. The introduction of smaller and easy-to-operate laser systems will further expand applications of flow cytometry to routine clinical laboratories. Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-troubleshooting, auto-calibration and other advanced features. Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine.
Geographic Regions and Countries
Asia-Pacific
Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam
Europe
Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Kazakhstan, Latvia, Lithuania, Malta, Moldova, Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, Ukraine
Latin America
Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
Middle East
Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates
North America
Canada, Mexico, USA
Strategic Recommendations
Sales and market shares of major instrument and reagent suppliers in major countries.
Hematology Tests Analyzed in the Report
CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils
Flow Cytometry Tests Analyzed in the Report
Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing
Instrumentation Review
Reviews of current instrumentation technologies, and features of leading hematology, flow cytometry, platelet aggregation and sedimentation rate analyzers.
The report features analyzers marketed by Abbott, Beckman Coulter/Danaher, Becton Dickinson, Biocode Hycel, CellaVision, Diesse Ves Matic, Drew-Scientific, Horiba, Medica, Menarini, Nihon Kohden, Polymedco, Siemens, Sysmex and other suppliers.
Technology Review
Strategic profiles of major suppliers and emerging market entrants.
The report is available by section, and can be customized to specific information needs and budget.
This survey from LeadingMarketResearch.com provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities emerging in the global hematology and flow cytometry markets during the next five years.
Rationale
Continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays. The introduction of smaller and easy-to-operate laser systems will further expand applications of flow cytometry to routine clinical laboratories. Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-troubleshooting, auto-calibration and other advanced features. Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine.
Geographic Regions and Countries
Asia-Pacific
Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam
Europe
Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Kazakhstan, Latvia, Lithuania, Malta, Moldova, Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, Ukraine
Latin America
Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
Middle East
Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates
North America
Canada, Mexico, USA
Strategic Recommendations
- New product development opportunities with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
- Sales and market share estimates of leading hematology and flow cytometry product suppliers in major countries.
- Specimen, test and sales forecasts for over 40 procedures.
Sales and market shares of major instrument and reagent suppliers in major countries.
Hematology Tests Analyzed in the Report
CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils
Flow Cytometry Tests Analyzed in the Report
Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing
Instrumentation Review
Reviews of current instrumentation technologies, and features of leading hematology, flow cytometry, platelet aggregation and sedimentation rate analyzers.
The report features analyzers marketed by Abbott, Beckman Coulter/Danaher, Becton Dickinson, Biocode Hycel, CellaVision, Diesse Ves Matic, Drew-Scientific, Horiba, Medica, Menarini, Nihon Kohden, Polymedco, Siemens, Sysmex and other suppliers.
Technology Review
- Assessment of current and emerging technologies and their potential market applications.
- Companies developing or marketing new technologies and products by test.
Strategic profiles of major suppliers and emerging market entrants.
I. INTRODUCTION
II. WORLDWIDE MARKET OVERVIEW
III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
V. ALTERNATIVE MARKET PENETRATION STRATEGIES
VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
VII. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Routine and Special Hematology Tests
1. Introduction
2. CBC Analysis
a. Hemoglobin Concentration
b. Hematocrit Determination
c. Red Blood Cell Count
d. Red Cell Indices
MCV
RDW
MCHC
CHCM
HDW
MCH
e. Red Cell Size Histograms
f. Platelets
Platelet Count
Platelet Size/MPV
PDW
Automated Systems
g. Reticulocytes
3. White Blood Cell Analysis
a. WBC Count
b. Five-Partial Differential Major Suppliers
c. Pattern Recognition Systems
d. Comparison of Major Differential Analyzers
4. Reticulocytes
5. Platelet Function Tests
6. Erythrocyte Sedimentation Rate/CRP
7. Red Cell Analysis
8. 2, 3 DPG
9. Red Cell Deformability
10. Neutrophil Function Tests
11. Semen Analysis
12. Bone Marrow Analysis
13. Urinalysis
B. Major Flow Cytometry Applications
1. Cell Surface Markers
a. Lymphocyte Subclassification CD4/CD8/CD34
Instrumentation and Reagent Test Kits
b. Other Cell Markers
2. DNA Content Analysis
3. RNA Content Analysis
4. Chemotherapy Monitoring
5. Cell Cycle Analysis
6. Chromosome Analysis
7. Fetal Cell Analysis
8. HLA Typing
9. Microbiology
10. Protein Content Analysis
11. Multiparameter Analysis
12. Other Applications
C. Hematology and Flow Cytometry Instrumentation Review
1. Hematology Analyzers
a. Overview
Electrical Aperture-Impedance Analyzers
Light Scatter Analyzers
b. Review of major analyzers from:
Abbott, Beckman Coulter/Danaher, Bio-Rad, CellaVision, Horiba, Nihon Kohden, Sekisui Diagnostics, Siemens Healthineers, Sysmex, and other suppliers.
2. Flow Cytometers
a. Introduction
b. System Overview
3. Platelet Aggregometers
4. Sedimentation Rate Analyzers
D. Market Needs and Future Demand
for Hematology and Flow Cytometry Analyzers
E. Reagents and Controls
F. Current and Emerging Technologies
1. Information Technologies
2. Automation and Robotics
3. Lasers
4. Artificial Intelligence
5. Monoclonal Antibodies
6. Molecular Diagnostics
7. Microdrop Technology
VII. COUNTRY MARKET ANALYSES: HEMATOLOGY AND FLOW CYTOMETRY TEST
Volume and Sales Forecasts for 97 Countries
Albania, Algeria, Argentina, Australia, Austria, Bahrain, Bangladesh, Belarus, Belgium, Bolivia, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, El Salvador, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, Haiti, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kuwait, Latvia, Lebanon, Lithuania, Malaysia, Malta, Mexico, Moldova, Morocco, Myanmar, Netherlands, New
Zealand, Nicaragua, Nigeria, Norway, Oman, Pakistan, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovak Republic, Slovenia, South Korea, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, UK, Ukraine, United Arab Emirates, Uruguay, USA, Venezuela, Vietnam
VIII. COMPETITIVE ASSESSMENTS
The report provides strategic assessments of over 15 leading hematology and flow cytometry market players and start-up companies with innovative
technologies and products, including:
Abbott
Agilent Technologies
Beckman Coulter/Danaher
Becton Dickinson
Bio-Rad
CellaVision
Horiba
Mindray
Nihon Kohden
Ortho-Clinical Diagnostics
Roche
Sekisui Diagnostics
Siemens Healthineers
Sysmex and others
II. WORLDWIDE MARKET OVERVIEW
III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
V. ALTERNATIVE MARKET PENETRATION STRATEGIES
VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
VII. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Routine and Special Hematology Tests
1. Introduction
2. CBC Analysis
a. Hemoglobin Concentration
b. Hematocrit Determination
c. Red Blood Cell Count
d. Red Cell Indices
MCV
RDW
MCHC
CHCM
HDW
MCH
e. Red Cell Size Histograms
f. Platelets
Platelet Count
Platelet Size/MPV
PDW
Automated Systems
g. Reticulocytes
3. White Blood Cell Analysis
a. WBC Count
b. Five-Partial Differential Major Suppliers
c. Pattern Recognition Systems
d. Comparison of Major Differential Analyzers
4. Reticulocytes
5. Platelet Function Tests
6. Erythrocyte Sedimentation Rate/CRP
7. Red Cell Analysis
8. 2, 3 DPG
9. Red Cell Deformability
10. Neutrophil Function Tests
11. Semen Analysis
12. Bone Marrow Analysis
13. Urinalysis
B. Major Flow Cytometry Applications
1. Cell Surface Markers
a. Lymphocyte Subclassification CD4/CD8/CD34
Instrumentation and Reagent Test Kits
b. Other Cell Markers
2. DNA Content Analysis
3. RNA Content Analysis
4. Chemotherapy Monitoring
5. Cell Cycle Analysis
6. Chromosome Analysis
7. Fetal Cell Analysis
8. HLA Typing
9. Microbiology
10. Protein Content Analysis
11. Multiparameter Analysis
12. Other Applications
C. Hematology and Flow Cytometry Instrumentation Review
1. Hematology Analyzers
a. Overview
Electrical Aperture-Impedance Analyzers
Light Scatter Analyzers
b. Review of major analyzers from:
Abbott, Beckman Coulter/Danaher, Bio-Rad, CellaVision, Horiba, Nihon Kohden, Sekisui Diagnostics, Siemens Healthineers, Sysmex, and other suppliers.
2. Flow Cytometers
a. Introduction
b. System Overview
3. Platelet Aggregometers
4. Sedimentation Rate Analyzers
D. Market Needs and Future Demand
for Hematology and Flow Cytometry Analyzers
E. Reagents and Controls
F. Current and Emerging Technologies
1. Information Technologies
2. Automation and Robotics
3. Lasers
4. Artificial Intelligence
5. Monoclonal Antibodies
6. Molecular Diagnostics
7. Microdrop Technology
VII. COUNTRY MARKET ANALYSES: HEMATOLOGY AND FLOW CYTOMETRY TEST
Volume and Sales Forecasts for 97 Countries
Albania, Algeria, Argentina, Australia, Austria, Bahrain, Bangladesh, Belarus, Belgium, Bolivia, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, El Salvador, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, Haiti, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kuwait, Latvia, Lebanon, Lithuania, Malaysia, Malta, Mexico, Moldova, Morocco, Myanmar, Netherlands, New
Zealand, Nicaragua, Nigeria, Norway, Oman, Pakistan, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovak Republic, Slovenia, South Korea, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, UK, Ukraine, United Arab Emirates, Uruguay, USA, Venezuela, Vietnam
VIII. COMPETITIVE ASSESSMENTS
The report provides strategic assessments of over 15 leading hematology and flow cytometry market players and start-up companies with innovative
technologies and products, including:
Abbott
Agilent Technologies
Beckman Coulter/Danaher
Becton Dickinson
Bio-Rad
CellaVision
Horiba
Mindray
Nihon Kohden
Ortho-Clinical Diagnostics
Roche
Sekisui Diagnostics
Siemens Healthineers
Sysmex and others